Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Brenner, Barry M., Cooper, Mark E., de Zeeuw, Dick, Keane, William F., Mitch, William E., Parving, Hans-Henrik, Remuzzi, Giuseppe, Snapinn, Steven M. +2 more·2001·New England Journal of Medicine

DOI 10.1056/nejmoa011161

Cited by (7,499)

Items 201–300 of 7,499

2013 ESH/ESC Guidelines for the management of arterial hypertension
Giuseppe Mancia, Robert H. Fagard, Krzysztof Narkiewicz, Josep Redón, Alberto Zanchetti, Michael Böhm, Thierry CM Christiaens, Renata Cífková, Guy De Backer, Anna F. Dominiczak et al. · 2013 · Blood Pressure
Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease
William B. Horton, Eugene J. Barrett · 2020 · Endocrine Reviews
Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events
Paul M. Ridker, Nancy Jeanne Brown, Douglas E. Vaughan, David Glenn Harrison, Jawahar L. Mehta · 2004 · Circulation
Pathophysiology of Hypertensive Renal Damage
ANIL K. BIDANI, Karen A. Griffin · 2004 · Hypertension
Guidelines for the management of chronic kidney disease
Adeera Levin, Brenda R. Hemmelgarn, Bruce F. Culleton, Sheldon W. Tobe, Phil McFarlane, Marcel Ruzicka, Kevin D. Burns, Braden Manns, C. White, François Madore et al. · 2008 · Canadian Medical Association Journal
The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study
Keane, William F., Brenner, Barry M., de Zeeuw, Dick, Grunfeld, Jean-Pierre, McGill, Janet, Mitch, William E., Ribeiro, Artur B., Shahinfar, Shahnaz, Simpson, Roger L., Snapinn, Steven M. et al. · 2003 · Kidney International
Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system
Blood Pressure Lowering Treatment Trialists' Collaboration · 2007 · Journal of Hypertension
Vascular Complications of Diabetes
Joshua A. Beckman, Mark A. Creager · 2016 · Circulation Research
Nonalbuminuric Renal Insufficiency in Type 2 Diabetes
Richard J. MacIsaac, Con Tsalamandris, Sianna Panagiotopoulos, Trudy J. Smith, Karen J. McNeil, George Jerums · 2004 · Diabetes Care
Evaluation of Kidney Function Throughout the Heart Failure Trajectory – A Position Statement from the Heart Failure Association of the European Society of Cardiology
Wilfried Müllens, Kevin Damman, Jeffrey Moore Testani, Pieter Martens, Christian Eugen Mueller, Johan P.E. Lassus, W.H. Wilson Tang, Hadi N. Skouri, Frederik Hendrik Verbrugge, Francesco Orso et al. · 2020 · European Journal of Heart Failure
Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial
Chariclia Gouva, Petros M. Nikolopoulos, John P. A. Ioannidis, Kostas C. Siamopoulos · 2004 · Kidney International
Diabetic Nephropathy: An Overview
Manpreet K. Sagoo, Luigi Gnudi · 2019 · Methods in molecular biology
Heart Failure
David S.H. Bell · 2003 · Diabetes Care
Management of Hypertension in Chronic Kidney Disease
Dan Pugh, Peter James Gallacher, Neeraj Dhaun · 2019 · Drugs
Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy
Tomás Berl, Lawrence G. Hunsicker, Julia Breyer Lewis, Marc Alan Pfeffer, Jerome G. Porush, Jean Lucien Rouleau, Paul Drury, Enric Esmatjes, Donald E. Hricik, Chirag R. Parikh et al. · 2003 · Annals of Internal Medicine
Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction
James B. Young, Mark E. Dunlap, Marc Alan Pfeffer, Jeffrey L. Probstfield, Alain Cohen Solal, Rainer Dietz, Christopher Bull Granger, J Hradec, Jerzy Kuch, Robert Samuel McKelvie et al. · 2004 · Circulation
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019
American Diabetes Association · 2018 · Diabetes Care
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial
Bakris, George L., Pitt, Bertram, Weir, Matthew R., Freeman, Mason W., Mayo, Martha R., Garza, Dahlia, Stasiv, Yuri, Zawadzki, Rezi, Berman, Lance, Bushinsky, David A. · 2015 · JAMA
Advanced Glycation end Products, Oxidative Stress and Diabetic Nephropathy
Sho‐ichi Yamagishi, Takanori Matsui · 2010 · Oxidative Medicine and Cellular Longevity
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study
Lindholm, Lars H., Ibsen, Hans, Borch-Johnsen, Knut, Olsen, Michael Hecht, Wachtell, Kristian, Dahlöf, Björn, Devereux, Richard B., Beevers, Gareth, de Faire, Ulf, Fyhrquist, Frej et al. · 2002 · Journal of Hypertension
11. Microvascular Complications and Foot Care: <i>Standards of Medical Care in Diabetes—2021</i>
American Diabetes Association · 2021 · Diabetes Care
Diagnosis of Stable Ischemic Heart Disease: Summary of a Clinical Practice Guideline From the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons
Amir Qaseem, Stephan D. Fihn, Sankey Williams, Paul Dallas, Douglas K Owens, Paul Shekelle · 2012 · Annals of Internal Medicine
Diabetes and Vascular Disease
Thomas Felix Lüscher, Mark A. Creager, Joshua A. Beckman, Francesco Cosentino · 2003 · Circulation
The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease
Ursula C. Brewster, Mark Anthony Perazella · 2004 · The American Journal of Medicine
Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
Mehdi, Uzma F., Adams-Huet, Beverley, Raskin, Philip, Vega, Gloria L., Toto, Robert D. · 2009 · Journal of the American Society of Nephrology
Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials
Thomopoulos, Costas, Parati, Gianfranco, Zanchetti, Alberto · 2014 · Journal of Hypertension
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
Fox, Caroline S., Golden, Sherita Hill, Anderson, Cheryl, Bray, George A., Burke, Lora E., de Boer, Ian H., Deedwania, Prakash, Eckel, Robert H., Ershow, Abby G., Fradkin, Judith et al. · 2015 · Circulation
Progression of kidney dysfunction in the community-dwelling elderly
Brenda R. Hemmelgarn, J. Zhang, Braden Manns, Marcello A. Tonelli, Erik T. Larsen, William Amin Ghali, Danielle A. Southern, Kevin McLaughlin, Garth Mortis, Bruce F. Culleton · 2006 · Kidney International
Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review
Giovanni FM Strippoli, Maria E. Craig, Jonathan James Deeks, Francesco Paolo Schena, Jonathan C. Craig · 2004 · BMJ
Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials
The ONTARGET/TRANSCEND Investigators · 2004 · American Heart Journal
Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG outcome randomised, placebo-controlled trial
Cherney, David Z I, Zinman, Bernard, Inzucchi, Silvio E, Koitka-Weber, Audrey, Mattheus, Michaela, von Eynatten, Maximilian, Wanner, Christoph · 2017 · The Lancet Diabetes & Endocrinology
Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses
Brunström, Mattias, Carlberg, Bo · 2016 · BMJ
Screening for Proteinuria in US Adults
L. Ebony Boulware, Bernard G. Jaar, Michelle E. Tarver-Carr, Frederick L. Brancati, Neil R. Powe · 2003 · JAMA
Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease)
Gerald B. Appel, H. Terence Cook, Gregory S. Hageman, J. Charles Jennette, Michael J Kashgarian, Michael Kirschfink, John D. Lambris, Lynne D. Lanning, Hans Ulrich Lutz, Seppo Meri et al. · 2005 · Journal of the American Society of Nephrology
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes
Alessandro Doria, Andrzej T. Gałecki, Cathie Spino, Rodica Pop‐Busui, David Z.I. Cherney, Ildiko Lingvay, Afshin Parsa, Peter R Rossing, Ronald Jeremy Sigal, Maryam Afkarian et al. · 2020 · New England Journal of Medicine
Antiproteinuric effect of oral paricalcitol in chronic kidney disease
Rajiv Agarwal, Muralidhar Acharya, Jin Tian, Richard Hippensteel, Joel Z. Melnick, Ping Qiu, Laura A. Williams, DANIEL C. BATLLE · 2005 · Kidney International
11. Microvascular Complications and Foot Care: <i>Standards of Medical Care in Diabetes−2020</i>
American Diabetes Association · 2020 · Diabetes Care
Effects of Dietary Sodium and Hydrochlorothiazide on the Antiproteinuric Efficacy of Losartan
Liffert Vogt, Femke Waanders, Frans Boomsma, Dick de Zeeuw, Gerjan J Navis · 2008 · Journal of the American Society of Nephrology
Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide
Fabián Sanchis‐Gomar, Carl J. Lavie, Mandeep R. Mehra, Brandon Michael Henry, Giuseppe Lippi · 2020 · Mayo Clinic Proceedings
Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy
Raphael Schiffmann, David G. Warnock, Maryam Banikazemi, Jan Bultas, Gabor E. Linthorst, Seymour Packman, Sven Asger Sorensen, William Ross Wilcox, Robert J. Desnick · 2009 · Nephrology Dialysis Transplantation
Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy
Robert C. Atkins, Esther M. Briganti, Julia Breyer Lewis, Lawrence G. Hunsicker, Gregory Lee Braden, Paul J. Champion de Crespigny, Giacomo Deferrari, Paul Drury, Francesco Locatelli, Thomas B. Wiegmann et al. · 2005 · American Journal of Kidney Diseases
An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function
Holtkamp, Frank A., de Zeeuw, Dick, Thomas, Merlin C., Cooper, Mark E., de Graeff, Pieter A., Hillege, Hans J.L., Parving, Hans-Henrik, Brenner, Barry M., Shahinfar, Shahnaz, Lambers Heerspink, Hiddo J. · 2011 · Kidney International
Renin–angiotensin–aldosterone system blockade for cardiovascular diseases: current status
Terry KW, Kevin Ka‐Ho Kam, Bryan P. Yan, Yat‐Yin Lam · 2010 · British Journal of Pharmacology
Antihypertensive Therapy in the Presence of Proteinuria
Pantelis A. Sarafidis, Nitin Khosla, George L. Bakris · 2007 · American Journal of Kidney Diseases
ACE2, a new regulator of the renin–angiotensin system
Louise M. Burrell, Colin I. Johnston, Christos Tikellis, Mark Emmanuel Cooper · 2004 · Trends in Endocrinology and Metabolism
Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians
Amir Qaseem, Timothy J Wilt, Robert Rich, Linda L. Humphrey, Jennifer Frost, Mary Ann Forciea · 2017 · Annals of Internal Medicine
2007 ESH‐ESC Guidelines for the management of arterial hypertension
Giuseppe Mansia, Guy De Backer, Anna F. Dominiczak, Renata Cífková, Robert H. Fagard, Giuseppe Germanò, Guido M. Grassi, Anthony Michael Heagerty, Sverre Erik Kjeldsen, Stéphane Laurent et al. · 2007 · Blood Pressure
Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)
Ian H. de Boer, Kamlesh K. Khunti, Tami Sadusky, Katherine R. Tuttle, Joshua J. Neumiller, Connie M. Rhee, Sylvia E. Rosas, Peter R Rossing, George L. Bakris · 2022 · Kidney International
Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials
Nigel A. Calcutt, Mark Emmanuel Cooper, Tim S Kern, Ann Marie Schmidt · 2009 · Nature Reviews Drug Discovery
From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines
Bieke F. Schrijvers, An S. De Vriese, Allan Flyvbjerg · 2004 · Endocrine Reviews
Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials
Sripal Bangalore, Sunil Kumar, Sverre Erik Kjeldsen, Harikrishna J. Makani, Ehud Grossman, Jørn Wetterslev, Ajay Kumar Gupta, Peter Sever, Christian Nyfeldt Gluud, Franz H. Messerli · 2010 · The Lancet Oncology
Long-term Renal Outcomes of Patients With Type 1 Diabetes Mellitus and Microalbuminuria An Analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Cohort Microalbuminuria Outcomes in Type 1 Diabetes
Ian H. de Boer · 2011 · Archives of Internal Medicine
Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy
Christos Tikellis, Colin I. Johnston, Josephine Maree Forbes, Wendy C. Burns, Louise M. Burrell, John Risvanis, Mark Emmanuel Cooper · 2003 · Hypertension
Guidelines for the management of arterial hypertension
Philippe van de Borne · 2014 · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)
SGLT2 Inhibitors and the Diabetic Kidney
Paola Fioretto, Alberto Zambon, Marco Rossato, Luca Busetto, Roberto Vettor · 2016 · Diabetes Care
Renal Outcomes in High-Risk Hypertensive Patients Treated With an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker vs a Diuretic: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Rahman, Mahboob · 2005 · Archives of Internal Medicine
Sympathetic nervous activation in obesity and the metabolic syndrome—Causes, consequences and therapeutic implications
Gavin William Lambert, Nora E. Straznicky, Élisabeth Lambert, John B. Dixon, Markus Peter Schlaich · 2010 · Pharmacology & Therapeutics
RETRACTED: Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study
Seibu Mochizuki, Björn Dahlöf, Mitsuyuki Shimizu, Katsunori Ikewaki, Makoto Yoshikawa, Ikuo Taniguchi, Makoto Ohta, Taku Yamada, Kazuhiko Ogawa, Kiyoshi Kanae et al. · 2007 · The Lancet · Retracted
Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis
Csaba Pal Kovesdy, Kunihiro Matsushita, Yingying Sang, Nigel John Brunskill, Juan Jesús Carrero, Gabriel Chodick, Takeshi Hasegawa, Hiddo J.L. Heerspink, Atsushi Hirayama, Gijs W.D. Landman et al. · 2018 · European Heart Journal
Trajectories of kidney function in diabetes: a clinicopathological update
Megumi Oshima, Miho Shimizu, Masayuki Yamanouchi, Tadashi Toyama, Akinori Hara, Kengo Furuichi, Takashi Wada · 2021 · Nature Reviews Nephrology
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study11The data reported here were supplied by the United States Renal Data System. Interpretation of these data is the responsibility of the authors, and in no way should be seen as an official policy or interpretation of the U.S. government.
Robert N. Foley, Charles A. Herzog, Allan J. Collins · 2002 · Kidney International
Diagnosis and Management of Type 2 Diabetic Kidney Disease
Simit Doshi, Allon N. Friedman · 2017 · Clinical Journal of the American Society of Nephrology
Progression of nephropathy in type 2 diabetic patients
Kasper Rossing, Per Knud Christensen, Peter Hambak Hovind, Lise Tarnow, Peter R Rossing, Hans‐Henrik Parving · 2004 · Kidney International
Microalbuminuria and Cardiovascular Disease
Matthew R. Weir · 2007 · Clinical Journal of the American Society of Nephrology
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease
Stefano Bianchi, Roberto Bigazzi, V. M. Campese · 2006 · Kidney International
Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease
Alfred K. Cheung, Tara I. Chang, William C. Cushman, Susan L. Furth, Fan Fan Hou, Joachim H. Ix, Greg A. Knoll, Paul Muntner, Roberto Pecoits‐Filho, Mark J. Sarnak et al. · 2021 · Kidney International
Social Determinants of Racial Disparities in CKD
Norton, Jenna M., Moxey-Mims, Marva M., Eggers, Paul W., Narva, Andrew S., Star, Robert A., Kimmel, Paul L., Rodgers, Griffin P. · 2016 · Journal of the American Society of Nephrology
Diabetic Kidney Disease
Sonali Gupta, Mary Dominguez, Ladan Golestaneh · 2023 · Medical Clinics of North America
Aldosterone: effects on the kidney and cardiovascular system
Marie B Briet, Ernesto L. Schiffrin · 2010 · Nature Reviews Nephrology
Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems
Fredrik Palm, Maristela Lika Onozato, Zaiming Luo, Christopher Stuart Wilcox · 2007 · American Journal of Physiology-Heart and Circulatory Physiology
Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice
Susan B. Gurley, Alicia Jones Allred, Thu H. Le, Robert Griffiths, Lan Mao, Nisha Philip, Timothy Haystead, Mary Donoghue, Roger E. Breitbart, Susan L. Acton et al. · 2006 · Journal of Clinical Investigation
The Treatment of Hypertension in Adult Patients With Diabetes
Arauz-Pacheco, Carlos, Parrott, Marian A., Raskin, Philip · 2002 · Diabetes Care
Inflammation in Renal Diseases: New and Old Players
Vinícius Andrade‐Oliveira, Orestes Foresto‐Neto, Ingrid Kazue Mizuno Watanabe, Roberto Zatz, Niels Olsen Saraiva Câmara · 2019 · Frontiers in Pharmacology
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Juliana C.N. Chan, LL Lim, Nicholas J. Wareham, Jonathan E. Shaw, Trevor John Orchard, Ping Zhang, Eric S. H. Lau, Björn Eliasson, Alice P.S. Kong, Majid Ezzati et al. · 2020 · Figshare
Renin–Angiotensin System Inhibition in Advanced Chronic Kidney Disease
Sunil Bhandari, Samir P. Mehta, Arif Khwaja, John G.F. Cleland, Natalie J. Ives, Elizabeth A. Brettell, Marie Chadburn, Paul Cockwell · 2022 · New England Journal of Medicine
Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies
Enrique Morales, M.A. Valero, Miguel León, Eduardo Hernández, Manuel Praga · 2003 · American Journal of Kidney Diseases
Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment
Ernesto L. Schiffrin · 2004 · American Journal of Hypertension
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
Handelsman, Yehuda, Mechanick, Jeffrey I., Blonde, Lawrence, Grunberger, George, Bloomgarden, Zachary T., Bray, George A., Dagogo-Jack, Samuel, Davidson, Jaime A., Einhorn, Daniel, Ganda, Om et al. · 2011 · Endocrine Practice
Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/Indapamide in hypertensive subjects: comparison with atenolol
Gerard Michel London, Roland G Asmar, Michael F. O’Rourke, Michel E. Safar · 2004 · Journal of the American College of Cardiology
Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial
2014 · The Lancet Diabetes & Endocrinology
Characterization of ferroptosis in kidney tubular cell death under diabetic conditions
Seonghun Kim, Shin‐Wook Kang, Jeongho Joo, Seung Hyeok Han, Huiyoon Shin, Bo Young Nam, Jimin Park, Tae‐Hyun Yoo, Gyuri Kim, Pureunchowon Lee et al. · 2021 · Cell Death and Disease
Impact of Achieved Blood Pressure on Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial
Tomás Berl, Lawrence G. Hunsicker, Julia Breyer Lewis, Marc Alan Pfeffer, Jerome G. Porush, Jean Lucien Rouleau, Paul Drury, Enric Esmatjes, Donald E. Hricik, Marc A. Pohl et al. · 2005 · Journal of the American Society of Nephrology
Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
SHARP Collaborative Group · 2010 · American Heart Journal
Longitudinal Progression Trajectory of GFR Among Patients With CKD
Liang Li, Brad C. Astor, Julia Breyer Lewis, Bo Hu, Lawrence J. Appel, Michael S. Lipkowitz, Robert D. Toto, Xuelei Wang, Jackson T. Wright, Tom Greene · 2012 · American Journal of Kidney Diseases
The RAAS in the pathogenesis and treatment of diabetic nephropathy
Piero Luigi Ruggenenti, Paolo Cravedi, Giuseppe Remuzzi · 2010 · Nature Reviews Nephrology
Pirfenidone for Diabetic Nephropathy
Kumar Sharma, Joachim H. Ix, Anna Vachaparampil Mathew, Monique Cho, Axel C. Pflueger, Stephen Dunn, Barbara B. Francos, Shoba Sharma, Bonita E. Falkner, Tracy McGowan et al. · 2011 · Journal of the American Society of Nephrology
Diabetic nephropathy—emerging epigenetic mechanisms
Mitsuo V. Kato, Rama D Natarajan · 2014 · Nature Reviews Nephrology
Assessment and Treatment of Cardiovascular Risk in Prediabetes: Impaired Glucose Tolerance and Impaired Fasting Glucose
Ralph A. DeFronzo, Muhammad A Abdul‐Ghani · 2011 · The American Journal of Cardiology
Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006 and effects of medicare coverage
McWilliams, J. Michael, Meara, Ellen, Zaslavsky, Alan M., Ayanian, John Z. · 2009 · Annals of Internal Medicine
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
Perkovic, Vlado, Heerspink, Hiddo Lambers, Chalmers, John, Woodward, Mark, Jun, Min, Li, Qiang, MacMahon, Stephen, Cooper, Mark E., Hamet, Pavel, Marre, Michel et al. · 2013 · Kidney International
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Daniel W. Jones, Keith C. Ferdinand, Sandra J. Taler, Heather M. Johnson, Daichi Shimbo, Marwah Abdalla, M. Martine Altieri, Nisha Bansal, Natalie Ann Bello, Adam Phillip Bress et al. · 2025 · Hypertension
Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America
Gregory M. Lucas, Michael J. Ross, Peter G. Stock, Michael G. Shlipak, Christina M. Wyatt, Samir Kumar Gupta, Mohamed G. Atta, Kara Wools‐Kaloustian, Paul A. Pham, Leslie A. Bruggeman et al. · 2014 · Clinical Infectious Diseases
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article
Sharon A. Hunt, William T. Abraham, Marshall H. Chin, Arthur Michael Feldman, Gary S. Francis, Théodore G. Ganiats, Mariell L Jessup, Marvin A. Konstam, DONNA M. MANCINI, Keith Michl et al. · 2005 · Journal of the American College of Cardiology
Prevention Conference VI: Diabetes and Cardiovascular Disease
Barbara V. Howard, Beatriz L. Rodríguez, Peter H. Bennett, Maureen I Harris, Richard F. Hamman, Lewis H. Kuller, Thomas A. Pearson, Judith Wylie‐Rosett · 2002 · Circulation
Renal function in diabetic nephropathy
Pradeep Kumar Dabla · 2010 · World Journal of Diabetes
Autophagy in diabetic nephropathy
Ding, Yan, Choi, Mary E · 2015 · Journal of Endocrinology
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Zhanbo Zhang, Lin Sun, Yanbin Wang, Gang Ning, Andrew W. Minto, J. Kong, Richard John Quigg, Yaopeng Li · 2007 · Kidney International
Effect of Pravastatin on Loss of Renal Function in People with Moderate Chronic Renal Insufficiency and Cardiovascular Disease
Marcello A. Tonelli, Lemuel A. Moyé, Frank M. Sacks, Thom Cole, Gary C. Curhan · 2003 · Journal of the American Society of Nephrology
When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal
Alberto Zanchetti, Guido M. Grassi, Giuseppe Mancia · 2009 · Journal of Hypertension
Sodium Intake, ACE Inhibition, and Progression to ESRD
Stefan Vegter, Annalisa Perna, Maarten Jacobus Postma, Gerjan J Navis, Giuseppe Remuzzi, Piero Luigi Ruggenenti · 2011 · Journal of the American Society of Nephrology